1.Treatment of second primary malignant tumor induced by radiotherapy.
Guo-hao WU ; Fu-jin CHEN ; Zong-yuan ZENG ; Hao LI ; Guo-wu LIN ; Ming SONG ; Mao-wen WEI ; Guang-pu XU ; An-kui YANG ; Wen-kuan CHEN
Chinese Journal of Oncology 2003;25(3):275-277
OBJECTIVETo study the diagnosis and treatment of a second primary malignant tumor induced by previous radiotherapy.
METHODSFrom March 1970 to March 1997, 108 nasopharyngeal cancer (NPC) patients who developed a second primary malignant tumor induced by radiotherapy were treated. There were squamous carcinoma 43 (39.8%), sarcoma 26 (24.1%), malignant fibrous histiocytoma 14 (13.0%), adenoid cystic carcinoma 12 (11.1%), thyroid papillary adenocarcinoma 8 (7.4%) and malignant melanoma 5 (4.6%). Fifty patients underwent operation, 32 received radiotherapy, 18 received chemotherapy and 8 received operation combined with chemotherapy.
RESULTSThe 3- and 5-year tumor-free survival rates were 64.0% and 36.0% in the operation group. They were 34.4% and 18.8% in the radiotherapy group.
CONCLUSIONSurgery, if not contra-indicated, is the first choice for the second primary malignant tumor induced by radiotherapy. Aggressive treatment for these patients is, hence, indicated clinically.
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Neoplasms, Radiation-Induced ; diagnosis ; mortality ; therapy ; Neoplasms, Second Primary ; diagnosis ; mortality ; therapy ; Radiotherapy ; adverse effects ; Survival Rate
2.Diagnosis and surgical treatment of metachronous second primary lung cancer.
Fei-yue FENG ; De-chao ZHANG ; Xiang-yang LIU ; Yong-gang WANG ; You-sheng MAO
Chinese Journal of Surgery 2005;43(6):348-350
OBJECTIVETo review the experience of the diagnosis, surgical treatment and prognosis of metachronous second primary lung cancers.
METHODSBetween January 1983 and April 2004, 32 patients with metachronous second primary lung cancers were operated in our department. Clinical data of all these patients were reviewed retrospectively.
RESULTSThe initial procedures for their first primary lung cancers were lobectomy or pneumonectomy. Lobectomy or completion pneumonectomy for the second primary lung cancers were performed in 17 cases, limited pulmonary resection was done in 14 cases and exploration was in 1 case. The postoperative morbidity and mortality were 12% (4/32) and 3% (1/32), respectively. The 1-, 3-, and 5-year survival rate after second operation were 66% (19/29), 32% (9/28) and 19% (4/21), respectively.
CONCLUSIONSThe incidence of metachronous second primary lung cancers has been increasing gradually during recent years. The closely follow-up for patients undergoing resection for their first primary lung cancers is most important factor for improvement of the diagnosis of metachronous second primary lung cancers. Limited resection and incomplete lymph node dissection might be the factors contributing to the poor prognosis.
Adult ; Aged ; Female ; Humans ; Lung Neoplasms ; diagnosis ; mortality ; pathology ; surgery ; Lymph Node Excision ; Male ; Middle Aged ; Neoplasms, Second Primary ; diagnosis ; mortality ; pathology ; surgery ; Pneumonectomy ; methods ; Prognosis ; Retrospective Studies
3.Characteristics and Survival of Breast Cancer Patients with Multiple Synchronous or Metachronous Primary Cancers.
Janghee LEE ; Seho PARK ; Sanghwa KIM ; Jeeye KIM ; Jegyu RYU ; Hyung Seok PARK ; Seung Il KIM ; Byeong Woo PARK
Yonsei Medical Journal 2015;56(5):1213-1220
PURPOSE: Newly developed extra-mammary multiple primary cancers (MPCs) are an issue of concern when considering the management of breast cancer survivors. This study aimed to investigate the prevalence of MPCs and to evaluate the implications of MPCs on the survival of breast cancer patients. MATERIALS AND METHODS: A total of 8204 patients who underwent surgery at Severance Hospital between 1990 and 2012 were retrospectively selected. Clinicopathologic features and survival over follow-up periods of < or =5 and >5 years were investigated using univariate and multivariate analyses. RESULTS: During a mean follow-up of 67.3 months, 962 MPCs in 858 patients (10.5%) were detected. Synchronous and metachronous MPCs were identified in 23.8% and 79.0% of patients, respectively. Thyroid cancer was the most prevalent, and the second most common was gynecologic cancer. At < or =5 years, patients with MPCs were older and demonstrated significantly worse survival despite a higher proportion of patients with lower-stage MPCs. Nevertheless, an increased risk of death in patients with MPCs did not reach statistical significance at >5 years. The causes of death in many of the patients with MPCs were not related to breast cancer. Stage-matched analysis revealed that the implications of MPCs on survival were more evident in the early stages of breast disease. CONCLUSION: Breast cancer patients with MPCs showed worse survival, especially when early-stage disease was identified. Therefore, it is necessary to follow screening programs in breast cancer survivors and to establish guidelines for improving prognosis and quality of life.
Adult
;
Aged
;
Breast/pathology
;
Breast Neoplasms/diagnosis/*mortality
;
Female
;
Humans
;
Middle Aged
;
Multivariate Analysis
;
Neoplasm Metastasis
;
Neoplasm Staging
;
Neoplasms, Multiple Primary/diagnosis/*mortality
;
Neoplasms, Second Primary/diagnosis/*mortality
;
Prognosis
;
*Quality of Life
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
Survival Analysis
4.Dietary Patterns Assessed by the Diet Quality Index-International Among Cancer Survivors Compared with Healthy Control Subjects: Using the Korea National Health and Nutrition Examination Surveys 2013–2015
Yoojin LEE ; Hye Yeon KOO ; In Young CHO ; Minkyeung JO ; Kyung Chul KIM ; Yoon Hee EUM ; Ju Young KIM ; Kiheon LEE ; Kee Hyuck LEE ; Se Young JUNG ; Hyejin LEE ; Sarah KIM ; Jong Soo HAN ; Woo Kyung BAE
Korean Journal of Family Practice 2019;9(2):204-211
BACKGROUND: Dietary patterns have a significant impact on prognosis, recurrence, and survival in patients with cancer. This study investigated dietary patterns using the Diet Quality Index-International (DQI-I) in cancer survivors compared to those in the general population without cancer.METHODS: Using the Korea National Health and Nutrition Examination Survey VI data, cancer survivors were defined as those diagnosed with cancer more than 1 year before the survey. The associations between possible predictors and the DQI-I score were examined using t-tests and analysis of variance. Adjusted multiple linear regression analysis was performed to compare the differences in DQI-I scores between cancer survivors and controls.RESULTS: In univariate analysis of 9,351 subjects (433 cancer survivors and 8,918 controls), age, sex, body mass index, marital status, education level, income, residential area, smoking status, and alcohol consumption were associated with the DQI-I score (each P-value < 0.05). After adjustment, cancer survivors showed higher DQI-I scores than the controls (67.40±8.90 vs. 65.50±9.40, P-value=0.007). In subgroup analysis, cancer survivors within 5 years after cancer diagnosis showed higher DQI-I scores than the controls (68.70±8.30 vs. 65.50±9.40, P-value=0.034), whereas those who survived beyond 5 years post-diagnosis did not show significant differences from the controls (66.70±9.20 vs. 65.50±9.40, P-value=0.063).CONCLUSION: Cancer survivors within 5 years of cancer diagnosis showed better dietary patterns than those in the general population. However, the differences were not observed after 5 years post-diagnosis. To reduce the risks of second primary cancer and mortality, targeted inventions for dietary habits are necessary for long-term survivors of cancer.
Alcohol Drinking
;
Body Mass Index
;
Diagnosis
;
Diet
;
Education
;
Food Habits
;
Humans
;
Inventions
;
Korea
;
Linear Models
;
Marital Status
;
Mortality
;
Neoplasms, Second Primary
;
Nutrition Surveys
;
Prognosis
;
Recurrence
;
Smoke
;
Smoking
;
Survivors
5.Characteristics and Outcomes of Second Malignant Neoplasms after Childhood Cancer Treatment: Multi-Center Retrospective Survey.
Kyung Nam KOH ; Keon Hee YOO ; Ho Joon IM ; Ki Woong SUNG ; Hong Hoe KOO ; Hyo Sun KIM ; Jung Woo HAN ; Jong Hyung YOON ; Hyeon Jin PARK ; Byung Kiu PARK ; Hee Jo BAEK ; Hoon KOOK ; Jun Ah LEE ; Jae Min LEE ; Kwang Chul LEE ; Soon Ki KIM ; Meerim PARK ; Young Ho LEE ; Chuhl Joo LYU ; Jong Jin SEO
Journal of Korean Medical Science 2016;31(8):1254-1261
This retrospective study investigated the clinical characteristics and outcomes of second malignant neoplasms (SMNs) in survivors of childhood cancer from multiple institutions in Korea. A total of 102 patients from 11 institutions who developed SMN after childhood cancer treatment between 1998 and 2011 were retrospectively enrolled. The most common primary malignant neoplasms (PMNs) were central nervous system (CNS) tumors (n = 17), followed by acute lymphoblastic leukemia (n = 16), non-Hodgkin lymphoma (n = 13), and osteosarcoma (n = 12). The most common SMNs were therapy-related myeloid neoplasms (t-MNs; acute myeloid leukemia [AML], 29 cases; myelodysplastic syndrome [MDS], 12 cases), followed by thyroid carcinomas (n = 15) and CNS tumors (n = 10). The median latency period was 4.9 years (range, 0.5-18.5 years). Among 45 patients with solid tumors defined as an SMN, 15 (33%) developed the lesion in a field previously subjected to radiation. The 5-year overall survival (OS) rate of patients with an SMN was 45% with a median follow-up time of 8.6 years. Patients with AML, MDS, and CNS tumors exhibited the poorest outcomes with 5-year OS rates of 18%, 33%, and 32%, respectively, whereas those with second osteosarcoma showed comparable outcomes (64%) to patients with primary counterpart and those with second thyroid carcinoma had a 100% OS rate. Further therapeutic efforts are recommended to improve the survival outcomes in patients with SMNs, especially in cases with t-MNs and CNS tumors.
Adolescent
;
Antineoplastic Agents/therapeutic use
;
Central Nervous System Neoplasms/diagnosis/drug therapy/radiotherapy
;
Child
;
Child, Preschool
;
Disease-Free Survival
;
Hospitals
;
Humans
;
Infant
;
Leukemia, Myeloid, Acute/diagnosis/epidemiology/mortality/therapy
;
Myelodysplastic Syndromes/diagnosis/epidemiology/mortality/therapy
;
Neoplasms, Second Primary/*diagnosis/epidemiology/mortality/therapy
;
Osteosarcoma/diagnosis/epidemiology
;
Retrospective Studies
;
Stem Cell Transplantation
;
Survival Rate
;
Transplantation, Autologous
;
Young Adult
6.Characteristics and Outcomes of Second Malignant Neoplasms after Childhood Cancer Treatment: Multi-Center Retrospective Survey.
Kyung Nam KOH ; Keon Hee YOO ; Ho Joon IM ; Ki Woong SUNG ; Hong Hoe KOO ; Hyo Sun KIM ; Jung Woo HAN ; Jong Hyung YOON ; Hyeon Jin PARK ; Byung Kiu PARK ; Hee Jo BAEK ; Hoon KOOK ; Jun Ah LEE ; Jae Min LEE ; Kwang Chul LEE ; Soon Ki KIM ; Meerim PARK ; Young Ho LEE ; Chuhl Joo LYU ; Jong Jin SEO
Journal of Korean Medical Science 2016;31(8):1254-1261
This retrospective study investigated the clinical characteristics and outcomes of second malignant neoplasms (SMNs) in survivors of childhood cancer from multiple institutions in Korea. A total of 102 patients from 11 institutions who developed SMN after childhood cancer treatment between 1998 and 2011 were retrospectively enrolled. The most common primary malignant neoplasms (PMNs) were central nervous system (CNS) tumors (n = 17), followed by acute lymphoblastic leukemia (n = 16), non-Hodgkin lymphoma (n = 13), and osteosarcoma (n = 12). The most common SMNs were therapy-related myeloid neoplasms (t-MNs; acute myeloid leukemia [AML], 29 cases; myelodysplastic syndrome [MDS], 12 cases), followed by thyroid carcinomas (n = 15) and CNS tumors (n = 10). The median latency period was 4.9 years (range, 0.5-18.5 years). Among 45 patients with solid tumors defined as an SMN, 15 (33%) developed the lesion in a field previously subjected to radiation. The 5-year overall survival (OS) rate of patients with an SMN was 45% with a median follow-up time of 8.6 years. Patients with AML, MDS, and CNS tumors exhibited the poorest outcomes with 5-year OS rates of 18%, 33%, and 32%, respectively, whereas those with second osteosarcoma showed comparable outcomes (64%) to patients with primary counterpart and those with second thyroid carcinoma had a 100% OS rate. Further therapeutic efforts are recommended to improve the survival outcomes in patients with SMNs, especially in cases with t-MNs and CNS tumors.
Adolescent
;
Antineoplastic Agents/therapeutic use
;
Central Nervous System Neoplasms/diagnosis/drug therapy/radiotherapy
;
Child
;
Child, Preschool
;
Disease-Free Survival
;
Hospitals
;
Humans
;
Infant
;
Leukemia, Myeloid, Acute/diagnosis/epidemiology/mortality/therapy
;
Myelodysplastic Syndromes/diagnosis/epidemiology/mortality/therapy
;
Neoplasms, Second Primary/*diagnosis/epidemiology/mortality/therapy
;
Osteosarcoma/diagnosis/epidemiology
;
Retrospective Studies
;
Stem Cell Transplantation
;
Survival Rate
;
Transplantation, Autologous
;
Young Adult